# Edgewell Personal Care Company (EPC) fundamentals

Data as of 2026-09-08. NYSE, United States. Sector: Consumer Defensive / Household Products. Price $28.87, market value $1.3 billion.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Edgewell Personal Care Company reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / sales: 0.6×**. Each dollar of revenue is priced at 0.6×, a low multiple typical of thin-margin businesses or out-of-favour stocks.
- **Price / book: 0.9×**. The shares trade below book value, which can signal a bargain or a balance sheet the market doubts.
- **EV / EBITDA: 29.7×**. Enterprise value is 29.7× operating earnings before depreciation, the multiple that ignores how the company is financed; above 20× is demanding.
- **Free-cash-flow yield: 3.9%** (5-yr avg -3.0%). Free cash flow equals 3.9% of the market value, above its five-year average of -3.0%, so the shares are cheaper on cash than they have usually been.

## Profitability
- **Gross margin: 39.8%**. Edgewell Personal Care Company keeps 39.8% of revenue after the direct cost of what it sells.
- **Operating margin: 0.4%**. 0.4% of revenue is left after running the business, which leaves little cushion in a downturn.
- **Net margin: 1.1%**. 1.1% of each dollar of sales reaches the bottom line.
- **Return on equity: 1.6%**. 1.6% on shareholders' equity is weak; the business earns little on the capital its owners have in it.
- **Return on invested capital: 0.2%**. Return on all capital, debt included, is 0.2%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: -2.5%**. Each dollar of assets produces -2.5% of profit.

## Growth
- **Revenue growth (1 yr): -1.3%** (3-yr 0.8%/yr, 5-yr 2.7%/yr). Revenue fell 1.3% over the last year, against 2.7% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): -73.1%** (3-yr -34.1%/yr, 5-yr -15.6%/yr). Earnings per share fell 73.1%, slower than revenue, so margins compressed.
- **Free-cash-flow growth (3 yr): -3.2%/yr**. Free cash flow has compounded at -3.2% a year over three years, keeping pace with earnings: the growth is real cash.

## Financial health
- **Debt to equity: 0.89**. Debt is 0.89 times equity, moderate leverage.
- **Current ratio: 1.76** (quick 1.76). Current assets cover the next year's liabilities 1.76 times.
- **Altman Z-score: 1.76**. A Z-score of 1.76 is in the distress zone, a signal to examine the balance sheet closely.
- **Piotroski F-score: 5/9**. 5 of 9 checks pass: mixed.

## Dividends
- **Dividend yield: 2.08%** ($0.60 per share, trailing). Edgewell Personal Care Company yields 2.08%, a modest yield more typical of a growth-oriented payer.
- **Payout ratio: 115%** (54% of free cash flow). The dividend exceeds earnings (115% payout), though free cash flow still covers it.
- **Consecutive years of increases: 6**. 6 straight years of increases.
- **Dividend growth (5 yr): 32.0%/yr** (1-yr 0.0%). The dividend has compounded at 32.0% a year over five years, doubling roughly every 2 years at that pace.

## Price and momentum
- **Total return (1 yr): 25.3%** (YTD 71.8%, 3-mo 46.4%). The shares are up 25.3% over twelve months including dividends.
- **From 52-week high: -3.6%** (83.5% above the low). Trading within 5% of its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 56**. An RSI of 56 is neutral.
- **Beta (1 yr): 0.36** (volatility 42%). Beta of 0.36 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=EPC · Page: https://foliofundamentals.com/stocks/epc

Not investment advice.